The THRIVE Initiative: The Increasing Role of Targeted Biologics in Moderate-to-Severe Psoriasis

The THRIVE Initiative: The Increasing Role of Targeted Biologics in Moderate-to-Severe Psoriasis is organized by Med Learning Group.

Dates:
Release Date: Nov 22, 2019
Expiration Date: Nov 22, 2020

Accreditation:
Credit Designation Statement:
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Credit Information:
This program would be beneficial for nurses involved in the long-term treatment and management of patients with psoriasis.
CNE Credits:
1.0 ANCC Contact Hour

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

Description:
This case-based enduring activity will cover the long-term treatment and management of patients with psoriasis.

Objectives:
After completing the CME activity, learners should be better able to:
• Review the molecular causes of psoriasis, as well as treatments that target these pathophysiologic mechanisms
• Describe why psoriasis and cardiovascular disease are related, and the implications for CVD screening and management in patients with psoriasis
• Review the mechanisms of action and efficacy/safety data of new and investigational biologics for patients with moderate to severe psoriasis
• Assess ways in which to improve communication with psoriasis patients in order to maintain adherence and improve quality of life

Additional details will be posted as soon as information is available.